Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics Revenue

Protalix BioTherapeutics had revenue of $33.75M in the quarter ending March 31, 2026, with 85.26% growth. This brings the company's revenue in the last twelve months to $70.84M, up 32.65% year-over-year. In the year 2025, Protalix BioTherapeutics had annual revenue of $52.74M, down -1.23%.

• Revenue (ttm): $70.84M
• Revenue Growth: +32.65%
• P/S Ratio: 2.11
• Revenue / Employee: $337,969
• Employees: 226
• Market Cap: 161.14M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	52.74M	-655.00K	-1.23%
Dec 31, 2024	53.40M	-12.10M	-18.47%
Dec 31, 2023	65.49M	17.86M	37.48%
Dec 31, 2022	47.64M	9.29M	24.22%
Dec 31, 2021	38.35M	-24.55M	-39.03%
Dec 31, 2020	62.90M	8.21M	15.00%
Dec 31, 2019	54.69M	20.45M	59.73%
Dec 31, 2018	34.24M	13.16M	62.44%
Dec 31, 2017	21.08M	11.88M	129.13%
Dec 31, 2016	9.20M	4.84M	110.79%
Dec 31, 2015	4.36M	-	-

Data Source: Fiscal.ai Last updated: May 14, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error